![Defining demographic cohorts in clinical trial populations using large electronic health records databases](https://trinetx.com/wp-content/uploads/2024/01/Defining-demographic-cohorts-in-clinical-trial-populations-using-large-electronic-health-records-databases-1080x675.jpg)
![Defining demographic cohorts in clinical trial populations using large electronic health records databases](https://trinetx.com/wp-content/uploads/2024/01/Defining-demographic-cohorts-in-clinical-trial-populations-using-large-electronic-health-records-databases-1080x675.jpg)
![Demographic Analysis of Industry-Sponsored Alzheimer’s Disease Trial Populations in the United States](https://trinetx.com/wp-content/uploads/2024/01/Demographic-Analysis-of-Industry-Sponsored-Alzheimers-Disease-Trial-Populations-in-the-United-States-1080x675.jpg)
Demographic Analysis of Industry-Sponsored Alzheimer’s Disease Trial Populations in the United States
![The Complete Guide to GVP Module IX (GVP-IX) for Signal Management](https://trinetx.com/wp-content/uploads/2023/12/TriNetX-EVIDEX-Guide-to-GVP-Module-IX-for-Signal-Management-1080x675.jpg)
The Complete Guide to GVP Module IX (GVP-IX) for Signal Management
Using EVIDEX® for next generation signal management![Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review](https://trinetx.com/wp-content/uploads/2023/11/Use-of-Electronic-Health-Record-Data-for-Drug-Safety-Signal-Identification-A-Scoping-Review-1080x675.jpg)
Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review
Sharon E. Davis, Luke Zabotka, Rishi J. Desai, Shirley V. Wang, Judith C. Maro, Kevin Coughlin, José J. Hernández-Muñoz, Danijela Stojanovic, Nigam H. Shah & Joshua C. Smith![Racial and Ethnic Differences in Fatality Risk From COVID-19](https://trinetx.com/wp-content/uploads/2023/10/Racial-and-Ethnic-Differences-in-Fatality-Risk-From-COVID-19-1080x675.jpg)